Fact CheckerSign in

NCT04675294Active, not recruitingPhase 2

Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

A Phase 2 Study of ALX148 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

Source: ClinicalTrials.gov · Last updated 1 Aug 2025

Brief summary (registry, in English)

A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
189 (actual)
First submitted
15 Dec 2020
Start date
2 Apr 2021
Primary completion date
3 Mar 2025
Lead sponsor
ALX Oncology Inc.
NCT number
NCT04675294
EU CT number
2023-508340-22-00
EudraCT number
2020-004093-21

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 189
  • From 2 Apr 2021 to the primary completion date, 3 Mar 2025
  • 53 sites in 9 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior treatment with any anti-CD47 or anti-SIRPα agent.
  • Prior treatment with anti-PD-1 or PD-L1.

Other illness

  • Patients with known symptomatic CNS metastases or leptomeningeal disease requiring steroids.
  • History of (non-infectious) pneumonitis that required steroids or has current pneumonitis.

Who the study is looking for

  • Patients with metastatic or unresectable, recurrent head and neck squamous cell carcinoma (HNSCC) that is PD-L1 positive (CPS \> 1) and who have not received prior systemic therapy for their advanced disease.
  • Adequate bone marrow function.
  • Adequate renal and liver function.
  • Adequate ECOG performance status.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (53)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Brisbane and Womens Hospital
Coordinator of this site? Confirm its status
BrisbaneAustraliaUnknown status
Peter MacCallum Cancer Centre
Coordinator of this site? Confirm its status
MelbourneAustraliaUnknown status
Sir Charles Gairdner Hospital
Coordinator of this site? Confirm its status
PerthAustraliaUnknown status
St. Vincent's
Coordinator of this site? Confirm its status
SydneyAustraliaUnknown status
Ashford Cancer Centre Research
Coordinator of this site? Confirm its status
Windsor GardensAustraliaUnknown status
Cliniques universitaires Saint-Luc
Coordinator of this site? Confirm its status
BrusselsBelgiumUnknown status
AZ Groeninge
Coordinator of this site? Confirm its status
KortrijkBelgiumUnknown status
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumUnknown status
Hamilton Health Sciences-Juravinski Cancer Centre
Coordinator of this site? Confirm its status
HamiltonCanadaUnknown status
LHSC Victoria Hospital
Coordinator of this site? Confirm its status
LondonCanadaUnknown status
Ottawa Hospital Cancer Centre
Coordinator of this site? Confirm its status
OttawaCanadaUnknown status
Princess Margaret Cancer Centre
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
Institud Catala d´Oncologia
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital Universitari Dexeus
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Hospital Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Severo Ochoa
Coordinator of this site? Confirm its status
MadridSpainUnknown status
HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Regional Universitario de Malaga
Coordinator of this site? Confirm its status
MálagaSpainUnknown status
Hospital Universitario de Navarra
Coordinator of this site? Confirm its status
PamplonaSpainUnknown status
Royal Marsden NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status
Royal Marsden NHS Foundation Trust
Coordinator of this site? Confirm its status
SuttonUnited KingdomUnknown status
Chungbuk National University Hospital
Coordinator of this site? Confirm its status
Cheongju-siSouth KoreaUnknown status
Yeungnam University Medical Center
Coordinator of this site? Confirm its status
DaeguSouth KoreaUnknown status
Chungnam National University Hospital
Coordinator of this site? Confirm its status
DaejeonSouth KoreaUnknown status
CHA University of Bundang
Coordinator of this site? Confirm its status
Gyeonggi-doSouth KoreaUnknown status
Gachon University Gil Medical Center
Coordinator of this site? Confirm its status
IncheonSouth KoreaUnknown status
Seoul National University Bundang Hospital
Coordinator of this site? Confirm its status
SeongnamSouth KoreaUnknown status
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Korea University Medical Center (KUMC) - Korea University Anam Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Severance Hospital Yonsei University
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
SNU Boramae Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Catholic University of Korea, St. Vincent's Hospital Suwon
Coordinator of this site? Confirm its status
SuwonSouth KoreaUnknown status
Yonsei University Wonju Severance Christian Hospital
Coordinator of this site? Confirm its status
WŏnjuSouth KoreaUnknown status
VUMC Goederenontvangst
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status
Universitair Medisch Centrum Groningen
Coordinator of this site? Confirm its status
GroningenNetherlandsUnknown status
National University Cancer Institute
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
National Cancer Centre Singapore
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
University of Maryland Medical System
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Rush University Medical Center
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
The Ohio State University
Coordinator of this site? Confirm its status
ColumbusUnited StatesUnknown status
Houston Methodist Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Hoag Hospital
Coordinator of this site? Confirm its status
IrvineUnited StatesUnknown status
University of California San Diego
Coordinator of this site? Confirm its status
La JollaUnited StatesUnknown status
Memorial Sloan Kettering Cancer Center
Coordinator of this site? Confirm its status
Long Island CityUnited StatesUnknown status
Northwest Georgia Oncology Centers
Coordinator of this site? Confirm its status
MariettaUnited StatesUnknown status
Vanderbilt-Ingram Cancer Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
Rutgers Cancer Institute of New Jersey
Coordinator of this site? Confirm its status
NewarkUnited StatesUnknown status
Oregon Health Science University
Coordinator of this site? Confirm its status
PortlandUnited StatesUnknown status
Blessing Cancer Center
Coordinator of this site? Confirm its status
QuincyUnited StatesUnknown status
H Lee Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.